Butorphanol Market Size, Competitors & Forecast to 2032

The butorphanol market is entering a period of measured growth, shaped by evolving clinical protocols, regulatory dynamics, and supply chain realignment strategies. Senior decision-makers need a clear perspective on segment trends, therapeutic positioning, and procurement shifts to inform competitive strategies and operational planning.

Market Snapshot: Butorphanol Market Size, Growth, and Outlook

The butorphanol market expanded from USD 296.11 million in 2025 to USD 311.57 million in 2026, with future growth projected at a CAGR of 4.39%, reaching USD 400.17 million by 2032. This trend is supported by rising demand across perioperative, obstetric, and chronic pain management pathways, combined with global efforts to optimize opioid stewardship and shift towards multimodal analgesia approaches.

Scope & Segmentation of the Butorphanol Market

This report comprehensively covers the pharmacology, clinical applications, and key factors influencing butorphanol adoption, including:

Formulation Types: Injection (intramuscular, intravenous), nasal spray, tablet
Therapeutic Applications: Management of chronic pain, labor pain, and surgical pain
End-User Settings: Hospitals, ambulatory care centers, home healthcare providers
Distribution Channels: Hospital pharmacies, retail pharmacies, online pharmacies
Geographic Regions: Americas, Europe, Middle East & Africa, Asia-Pacific
Technology Platforms: Emphasis on advancements in intranasal and intravenous delivery systems

These segments highlight where clinical differentiation, procurement efficiency, and regulatory compliance intersect to influence adoption trends and market strategies.

Key Takeaways for Senior Decision-Makers

Butorphanol’s distinct profile as a mixed agonist-antagonist opioid offers advantages in patient populations where rapid, controllable analgesia with minimized respiratory risk is prioritized.
Multimodal pain management pathways are increasing interest in analgesics that align with opioid-sparing objectives, creating opportunities for agents with favorable sedation profiles and versatile administration routes.
Regulatory reforms and stewardship programs demand robust real-world evidence and clear labeling to support protocol inclusion and hospital formulary acceptance.
Innovations in supply chain resilience, including nearshoring and alternative sourcing strategies, are integral to maintaining access and cost control amidst shifting trade policies.
Regional variations in regulatory requirements and procurement models necessitate tailored market, pricing, and distribution approaches for expansion and sustained product uptake.
Educational engagement with anesthesiology, obstetric, and pharmacy stakeholders remains critical to shaping prescribing norms and supporting safe use.

Tariff Impact & Supply Chain Realignment

United States tariff measures in 2025 have introduced added complexity for sourcing butorphanol ingredients and finished formulations, impacting procurement costs and contributing to supply chain reevaluation. Manufacturers and purchasing organizations are adapting by diversifying suppliers, investing in nearshore production, and exploring risk-sharing contract strategies. These efforts aim to preserve product access and minimize disruptions associated with global trade shifts, underscoring the need for resilient and forward-looking operational planning in the butorphanol market.

Methodology & Data Sources

The report’s insights draw from structured reviews of peer-reviewed clinical literature, regulatory documentation, and professional guidelines, combined with stakeholder interviews involving clinicians, pharmacists, and supply chain experts. Analytical triangulation ensures findings reflect the intersection of clinical, operational, and policy developments relevant to butorphanol’s market positioning.

Why This Report Matters

Enables informed decision-making by clearly mapping how clinical, regulatory, and supply chain factors shape butorphanol adoption within evolving healthcare systems.
Supports strategic planning through segment-specific insights on formulation innovation, procurement strategies, and stakeholder engagement.
Assists in risk mitigation and opportunity assessment by detailing regional dynamics and actionable pathways for competitive differentiation.

Conclusion

Butorphanol remains a relevant option for targeted analgesic pathways, especially where rapid effect and opioid-sparing strategies are aligned with institutional protocols. Coordinated efforts across evidence, operations, and education are key to securing and sustaining product adoption amid ongoing industry transformation.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Butorphanol Market, by Route Of Administration

8.1. Injection
8.1.1. Intramuscular Injection
8.1.2. Intravenous Injection
8.2. Nasal Spray
8.3. Tablet

9. Butorphanol Market, by Distribution Channel

9.1. Hospital Pharmacy
9.2. Online Pharmacy
9.3. Retail Pharmacy

10. Butorphanol Market, by Application

10.1. Chronic Pain Management
10.2. Labor Pain Management
10.3. Surgical Pain Management

11. Butorphanol Market, by End User

11.1. Ambulatory Care Center
11.2. Home Healthcare
11.3. Hospital

12. Butorphanol Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Butorphanol Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Butorphanol Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Butorphanol Market
16. China Butorphanol Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Animedica
17.6. Animedica
17.7. Apotex Inc.
17.8. Apothecon Pharmaceuticals
17.9. Apothecon Pharmaceuticals
17.10. Athanas Enterprise Private Limited
17.11. B. Braun Melsungen AG
17.12. Baxter International Inc.
17.13. Boehringer Ingelheim
17.14. Boehringer Ingelheim
17.15. Bristol Myers Squibb
17.16. Bristol Myers Squibb
17.17. Dechra Pharmaceuticals
17.18. Dechra Pharmaceuticals
17.19. Faunapharma
17.20. Faunapharma
17.21. Fresenius Kabi AG
17.22. Hikal Limited
17.23. Hikal Limited
17.24. Hikma Pharmaceuticals PLC
17.25. Merck KGaA
17.26. Merck KGaA
17.27. Mylan N.V.
17.28. Novex Pharma
17.29. Novex Pharma
17.30. Pfizer Inc.
17.31. Richter Pharma AG
17.32. Richter Pharma AG
17.33. Sagent Pharmaceuticals, Inc.
17.34. Sandoz International GmbH
17.35. Sanochemia Pharmazeutika
17.36. Sanochemia Pharmazeutika
17.37. Selectavet
17.38. Selectavet
17.39. Taj Pharmaceuticals Ltd.
17.40. Taj Pharmaceuticals Ltd.
17.41. Teva Pharmaceutical Industries Ltd.
17.42. Troy Laboratories NZ
17.43. Troy Laboratories NZ
17.44. Zoetis Inc.
17.45. Zoetis Inc.

List of Figures

FIGURE 1. GLOBAL BUTORPHANOL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BUTORPHANOL MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BUTORPHANOL MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BUTORPHANOL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BUTORPHANOL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BUTORPHANOL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BUTORPHANOL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BUTORPHANOL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BUTORPHANOL MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL BUTORPHANOL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BUTORPHANOL MARKET SIZE, BY INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BUTORPHANOL MARKET SIZE, BY INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BUTORPHANOL MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BUTORPHANOL MARKET SIZE, BY INTRAMUSCULAR INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BUTORPHANOL MARKET SIZE, BY INTRAMUSCULAR INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BUTORPHANOL MARKET SIZE, BY INTRAMUSCULAR INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BUTORPHANOL MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BUTORPHANOL MARKET SIZE, BY INTRAVENOUS INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BUTORPHANOL MARKET SIZE, BY INTRAVENOUS INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BUTORPHANOL MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BUTORPHANOL MARKET SIZE, BY NASAL SPRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BUTORPHANOL MARKET SIZE, BY NASAL SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BUTORPHANOL MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BUTORPHANOL MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BUTORPHANOL MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BUTORPHANOL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BUTORPHANOL MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BUTORPHANOL MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BUTORPHANOL MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BUTORPHANOL MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BUTORPHANOL MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BUTORPHANOL MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BUTORPHANOL MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BUTORPHANOL MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BUTORPHANOL MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BUTORPHANOL MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BUTORPHANOL MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BUTORPHANOL MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BUTORPHANOL MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BUTORPHANOL MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BUTORPHANOL MARKET SIZE, BY SURGICAL PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BUTORPHANOL MARKET SIZE, BY SURGICAL PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BUTORPHANOL MARKET SIZE, BY SURGICAL PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BUTORPHANOL MARKET SIZE, BY AMBULATORY CARE CENTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BUTORPHANOL MARKET SIZE, BY AMBULATORY CARE CENTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BUTORPHANOL MARKET SIZE, BY AMBULATORY CARE CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BUTORPHANOL MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BUTORPHANOL MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BUTORPHANOL MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BUTORPHANOL MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BUTORPHANOL MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BUTORPHANOL MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BUTORPHANOL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. AMERICAS BUTORPHANOL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 51. AMERICAS BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 52. AMERICAS BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 53. AMERICAS BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 54. AMERICAS BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 56. NORTH AMERICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. NORTH AMERICA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 58. NORTH AMERICA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 59. NORTH AMERICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 60. NORTH AMERICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 61. NORTH AMERICA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 62. LATIN AMERICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. LATIN AMERICA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 64. LATIN AMERICA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 65. LATIN AMERICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 66. LATIN AMERICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 67. LATIN AMERICA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. EUROPE BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. EUROPE BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 76. EUROPE BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 77. EUROPE BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 78. EUROPE BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. EUROPE BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. MIDDLE EAST BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. MIDDLE EAST BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 82. MIDDLE EAST BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 83. MIDDLE EAST BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 84. MIDDLE EAST BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. MIDDLE EAST BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. AFRICA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 88. AFRICA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 89. AFRICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. AFRICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. AFRICA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BUTORPHANOL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. ASEAN BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. ASEAN BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 101. ASEAN BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 102. ASEAN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. ASEAN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. ASEAN BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. GCC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GCC BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 107. GCC BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 108. GCC BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. GCC BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. GCC BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPEAN UNION BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. EUROPEAN UNION BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 113. EUROPEAN UNION BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 114. EUROPEAN UNION BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. EUROPEAN UNION BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. EUROPEAN UNION BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. BRICS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. BRICS BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 119. BRICS BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 120. BRICS BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. BRICS BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. BRICS BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. G7 BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. G7 BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 125. G7 BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 126. G7 BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. G7 BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. G7 BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. NATO BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. NATO BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 131. NATO BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 132. NATO BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. NATO BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. NATO BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. UNITED STATES BUTORPHANOL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 137. UNITED STATES BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 138. UNITED STATES BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 139. UNITED STATES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. UNITED STATES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. UNITED STATES BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. CHINA BUTORPHANOL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 143. CHINA BUTORPHANOL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 144. CHINA BUTORPHANOL MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 145. CHINA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 146. CHINA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. CHINA BUTORPHANOL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Butorphanol market report include:

Animedica
Animedica
Apotex Inc.
Apothecon Pharmaceuticals
Apothecon Pharmaceuticals
Athanas Enterprise Private Limited
B. Braun Melsungen AG
Baxter International Inc.
Boehringer Ingelheim
Boehringer Ingelheim
Bristol Myers Squibb
Bristol Myers Squibb
Dechra Pharmaceuticals
Dechra Pharmaceuticals
Faunapharma
Faunapharma
Fresenius Kabi AG
Hikal Limited
Hikal Limited
Hikma Pharmaceuticals PLC
Merck KGaA
Merck KGaA
Mylan N.V.
Novex Pharma
Novex Pharma
Pfizer Inc.
Richter Pharma AG
Richter Pharma AG
Sagent Pharmaceuticals, Inc.
Sandoz International GmbH
Sanochemia Pharmazeutika
Sanochemia Pharmazeutika
Selectavet
Selectavet
Taj Pharmaceuticals Ltd.
Taj Pharmaceuticals Ltd.
Teva Pharmaceutical Industries Ltd.
Troy Laboratories NZ
Troy Laboratories NZ
Zoetis Inc.
Zoetis Inc.

Table Information

Report Attribute	Details
No. of Pages	188
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 311.57 Million
Forecasted Market Value ( USD ) by 2032	$ 400.17 Million
Compound Annual Growth Rate	4.3%
Regions Covered	Global
No. of Companies Mentioned	42

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3439EUR$3,939USD£2,978GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3710EUR$4,249USD£3,212GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5028EUR$5,759USD£4,353GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6085EUR$6,969USD£5,268GBP

Butorphanol Market - Global Forecast 2026-2032

Market Snapshot: Butorphanol Market Size, Growth, and Outlook

Scope & Segmentation of the Butorphanol Market

Key Takeaways for Senior Decision-Makers

Tariff Impact & Supply Chain Realignment

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot: Butorphanol Market Size, Growth, and Outlook

Scope & Segmentation of the Butorphanol Market

Key Takeaways for Senior Decision-Makers

Tariff Impact & Supply Chain Realignment

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Butorphanol (CAS 42408-82-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

Pain Management in Livestock Market - Global Forecast 2025-2030

Veterinary Anesthetic Drugs Market - Global Forecast 2025-2030

Opioid Analgesics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Pain Management Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

About the Butorphanol Market